METHOD FOR TREATING PATIENTS FOR NEOVASCULAR GLAUCOMA Russian patent published in 2006 - IPC A61F9/00 A61K31/409 A61N5/67 

FIELD: medicine.

SUBSTANCE: method involves translimbally exposing anterior chamber neovascularization angle projection zone to low intensity laser radiation field-by-field at wavelength of 633 nm at a dose of 2.5 J or at wavelength of 890 nm at a dose of 1.2 J. Water-soluble chlorine row photosensitizer dosage form is intravenously introduced at a bolus dose of 0.8-1.1 mg/kg. Newly formed blood vessels are exposed to radiation in 15-20 min after having accomplished photosensitizer introduction, field-by-field with diameter not greater than 3 mm and wavelength corresponding to maximum luminous flow absorption by the photosensitizer. Power density is equal to 50-80 J/cm². Irradiation is applied with neighboring fields overlap by 5% of area. The laser field covers anterior chamber angle structures and iris root zone. Irradiation zone is not to exceed 180° per one session along anterior chamber angle length. The treatment is completely repeated in 2-3 weeks in the zone remaining intact during the first session.

EFFECT: dosed action; reduced risk of traumatic complications; stable ophthalmotone and anterior chamber angle neovascularization regress.